Evidence map›Paper›PMID 42374616›Full record

ArticleAdvanced healthcare materials2026

Plasmonically Reinforced Self-Sufficient Nanozymes Dysregulating Redox Homeostasis for Augmented Cascade Catalytic Oncotherapy.

Han Wang, Mingyang Chen, Haiyan Chen, Jinghang Li, Ming Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Han WangSchool of Materials Science and Engineering, Central South University, Changsha, Hunan, China.
Mingyang ChenSchool of Materials Science and Engineering, Central South University, Changsha, Hunan, China.
Haiyan ChenSchool of Materials Science and Engineering, Central South University, Changsha, Hunan, China.
Jinghang LiSchool of Materials Science and Engineering, Central South University, Changsha, Hunan, China.
Ming LiSchool of Materials Science and Engineering, Central South University, Changsha, Hunan, China.ORCID https://orcid.org/0000-0002-2289-0222

Funding

Hunan Provincial Science & Technology Program 2017XK2027National Natural Science Foundation of China 51871246
6 · The paper itself

Abstract

Tumor nanocatalytic therapy represents a promising transformative technology for treating malignant tumors, yet is often limited by insufficient catalytic activity and adaptive tumor microenvironment (TME) resistance. Herein, we develop a plasmonic Pt-CuO

Indexed as

Metal NanoparticlesTriple Negative Breast NeoplasmsAnimalsCatalysisCell Line, TumorCopperFemaleGoldHomeostasisHumansHydrogen PeroxideHyperthermia, InducedImidazolesMetal-Organic FrameworksMiceOxidation-ReductionCoppercupric oxideGoldHydrogen PeroxideImidazolesMetal-Organic FrameworksPlatinumZIF-8 metal-organic frameworkcascade catalytic reactionscatalytic therapyH2O2 self‐supplyplasmonic enhancementredox imbalance

Identifiers

PMID42374616
PMCPMC13447933

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.